SCHEMBL3757536

SCHEMBL3757536

CN(C)Cc1c(N2CCOCC2)sc2c1CC(C)(C)CC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.47
PIK3CD O00329 6/20 0.47
PIK3CB P42338 5/20 0.47
PIK3CG P48736 5/20 0.47
ALDH1A1 P00352 8/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
BRD4 O60885 1/20 0.38
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
USP2 O75604 1/20 0.37
POLB P06746 1/20 0.37
ALOX15 P16050 1/20 0.37
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
HSD17B10 Q99714 3/20 0.32
KDM4E B2RXH2 2/20 0.32
GAA P10253 2/20 0.32
CASP1 P29466 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766105 0.79 PIK3CA (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3764964 0.79 PIK3CA (0.55) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3758728 0.79 PIK3CA (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3764741 0.79 PIK3CA (0.52) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3759877 0.78 PIK3CD (0.39) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3759346 0.78 AOC3 (0.39) PIK3CAPIK3CDPIK3CBPIK3CGSMN1; SMN2
SCHEMBL3760327 0.77 PIK3CA (0.50) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3766924 0.77 PIK3CD (0.50) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3762230 0.76 PIK3CA (0.39) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3751935 0.76 AOC3 (0.40) PIK3CAPIK3CDPIK3CBPIK3CGBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.